Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
SONATA: Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
Dartmouth-Hitchcock Medical Center
24 participants
Jul 22, 2025
INTERVENTIONAL
Conditions
Summary
This is a prospective, placebo-controlled, double-blinded randomized study of self-administered auditory intervention in a naturalistic home environment.
Eligibility
Inclusion Criteria4
- Adults with medication-refractory focal epilepsy who have undergone RNS implantation at least six months prior and are in the judgement of the treating physician on a stable RNS regimen in terms of stimulation
- Willing to attend all study visits and complete all required study procedures
- Access to private or public wireless data service at regular intervals
- Access to personal mobile device
Exclusion Criteria3
- Documentation of a musicogenic, or auditory-triggered focal seizure semiology
- Participant is unable to reasonably participate in study tasks as determined by the investigator
- Inability to obtain informed consent from the patient or legally authorized representative
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will be asked to listen to Music A on their personal device daily, at a time most convenient for them.
Participants will be asked to listen to music B on their personal device daily, at a time most convenient for them.
Participants will be asked to listen to music C on their personal device daily, at a time most convenient for them.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06425029